Marcom that brings
biotech to life

SciStories helps smart, progressive biotech companies find and talk to investors, partners, future employees, and customers.

Our Services

Most Popular

Full-Service Agency

our-services-img

Websites

our-services-img

Explainers

our-services-img

Slide Presentations

our-services-img

Other Services

Branding

our-services-img

Datavis

our-services-img

Graphical Abstracts

our-services-img

Video & Animation

our-services-img

Photography

our-services-img

Social Media

our-services-img

Media Relations

our-services-img

Brochures

our-services-img

“SciStories was the right partner for the small, privately held biotech company
I co-founded in 2011 and they are the right partner for the publicly traded biotech company that I’m running today.”

quote-author-photo

Matt Angel, PhD

CEO
Eterna Therapeutics Inc.

Working with SciStories is easy

icon

Efficient Qualification

We move quickly to learn about your needs and educate your key decision makers about us.

icon

Experienced Contracting

We work efficiently with purchasing and legal from organizations of all size and complexity.

icon

Exceptional Service

Customized to the scale and nature of your needs, our provides world-class creative and attentive management.

Some SciStories Clients

FAQ

  1. “Biotech” is a diverse industry. Have you worked with companies like ours?
  2. Our technology is unique and patented, there is no way SciStories has worked with it before. So, why would SciStories be any better for us than other marketing firms?
  3. How large are SciStories’ biotech clients?
  4. This all sounds like a big commitment. I just need a small project done quickly at a great level of quality. Can SciStories help out?
  5. OK, so it’s clear that SciStories gets the science part. But what about the marketing part? The making beautiful things part? The getting-the-right-message-to-the-right-audience part? Maybe I’d be better off with someone who doesn’t know the science as well but is great at those things?

We may or may not have worked with a company doing just what you’re doing. But few – if any – marketing firms have worked with such a diverse range of biotech clients. We have particularly deep expertise working with CRO’s (Contract Research Organizations) ranging from technology and testing to drug discovery and development to pre-clinical research and clinical stage trials and management. We also have experience with CDMO’s (Contract Development Manufacturing Organizations), especially vaccine manufacturers. This breadth of work across the biotech industry not only gives us pre-loaded insight into new clients in the fields we are experienced in but also gives us broad global context that makes it quick and easy for us to norm into corners of the industry we haven’t explored yet.

Congratulations! We know how exciting it is to control a powerful biotechnology that has the potential to create substantial value.

The nature of our business – our focus, our training, what we are exceptional at – is using our broad experience and understanding of more than 50 unique technologies to quickly and correctly understand what the essence of a new client’s technology in order to help them best achieve their strategic objectives. We may not have worked with exactly what you are doing, but we are going to get it more quickly and deeply than other communication partners.

Here are examples of specific technologies we’ve worked with:

  • mRNA technologies
  • AI- and ML-assisted technologies
  • Computational research
  • Computational genomics
  • Gene therapies
  • Gene editing
  • Statistical genetics
  • Cell reprogramming
  • Engineered cell therapies
  • Anellovirus technologies
  • Single-cell technologies
  • Cancer immunotherapy
  • Immuno-oncology
  • Drug engineering
  • Small molecule immunomodulators
  • Precision pathology/Precision medicine

We work with small-to-medium-sized biotech companies. These generally fit two profiles:

  • Early stage, with $5-25M in investment capital. Here, our direct contact is usually part of the C-suite, typically even the CEO. They have reached the point where they know good marketing communications are required for them to hit their next strategic milestones. These triggers span a variety of activities, such as attracting investors or partners, hiring key personnel, selling or training physicians on a clinical trial, and managing the media.
  • Established, up to $1B in investment capital or total market cap. Here, we often work with multiple stakeholders to contribute to diverse communication initiatives across the organization. This can span the executive team, R&D, HR, marketing, and sales orgs.

Definitely! Most of our large, long-term clients began with just one small – and probably urgent – project: a slide deck for the CEO. A figure for a key researcher. A quick-and-dirty website to accompany an important moment. We are happy to work on things like this for their own sake, but we find that these small clients usually blossom into large ones. So, yes: bring on your small project. We’re here to help.

You’re right that the marketing communications side is every bit as important as the deep industry experience in science and technology. Our messaging emphasizes the science-y things because we think they are more rare, almost uniquely so, and will help people to find us. But the ultimate measure of quality marketing is about outcomes: what strategic objectives was a company able to realize, in part, thanks to the impact of their communications? Here is a partial list of real outcomes enjoyed by SciStories clients:

  • Gains NASDAQ listing
  • Acquired for $125M
  • Various 8 figure investment rounds
  • Various 7-8 figure licensing deals
  • Various 7-8 figure partnership deals

FAQ

  1. We may or may not have worked with a company doing just what you’re doing. But few – if any – marketing firms have worked with such a diverse range of biotech clients. We have particularly deep expertise working with CRO’s (Contract Research Organizations) ranging from technology and testing to drug discovery and development to pre-clinical research and clinical stage trials and management. We also have experience with CDMO’s (Contract Development Manufacturing Organizations), especially vaccine manufacturers. This breadth of work across the biotech industry not only gives us pre-loaded insight into new clients in the fields we are experienced in but also gives us broad global context that makes it quick and easy for us to norm into corners of the industry we haven’t explored yet.

  2. Congratulations! We know how exciting it is to control a powerful biotechnology that has the potential to create substantial value.

    The nature of our business – our focus, our training, what we are exceptional at – is using our broad experience and understanding of more than 50 unique technologies to quickly and correctly understand what the essence of a new client’s technology in order to help them best achieve their strategic objectives. We may not have worked with exactly what you are doing, but we are going to get it more quickly and deeply than other communication partners.

    Here are examples of specific technologies we’ve worked with:

    • mRNA technologies
    • AI- and ML-assisted technologies
    • Computational research
    • Computational genomics
    • Gene therapies
    • Gene editing
    • Statistical genetics
    • Cell reprogramming
    • Engineered cell therapies
    • Anellovirus technologies
    • Single-cell technologies
    • Cancer immunotherapy
    • Immuno-oncology
    • Drug engineering
    • Small molecule immunomodulators
    • Precision pathology/Precision medicine
  3. We work with small-to-medium-sized biotech companies. These generally fit two profiles:

    • Early stage, with $5-25M in investment capital. Here, our direct contact is usually part of the C-suite, typically even the CEO. They have reached the point where they know good marketing communications are required for them to hit their next strategic milestones. These triggers span a variety of activities, such as attracting investors or partners, hiring key personnel, selling or training physicians on a clinical trial, and managing the media.
    • Established, up to $1B in investment capital or total market cap. Here, we often work with multiple stakeholders to contribute to diverse communication initiatives across the organization. This can span the executive team, R&D, HR, marketing, and sales orgs.
  4. Definitely! Most of our large, long-term clients began with just one small – and probably urgent – project: a slide deck for the CEO. A figure for a key researcher. A quick-and-dirty website to accompany an important moment. We are happy to work on things like this for their own sake, but we find that these small clients usually blossom into large ones. So, yes: bring on your small project. We’re here to help.

  5. You’re right that the marketing communications side is every bit as important as the deep industry experience in science and technology. Our messaging emphasizes the science-y things because we think they are more rare, almost uniquely so, and will help people to find us. But the ultimate measure of quality marketing is about outcomes: what strategic objectives was a company able to realize, in part, thanks to the impact of their communications? Here is a partial list of real outcomes enjoyed by SciStories clients:

    • Gains NASDAQ listing
    • Acquired for $125M
    • Various 8 figure investment rounds
    • Various 7-8 figure licensing deals
    • Various 7-8 figure partnership deals

Can we help you?

The best way to find out is to get in touch. Once we learn about each other we can chart the best path forward together.